NI vs STRO · P/E 23, rev $5.28B vs rev $62.0M
NiSource Inc (NI) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported NI revenue for 2024-12-31 was $5.28B. Net income was $844.7M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NI currently screens at market cap $22.42B and trailing P/E 23.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NI and STRO stock pages for the full models.
Not investment advice.